600079.SHG Humanwell Healthcare Group Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
19.44 CNY
Close of Nov 4, 2026
16.03 20.95
Market cap
CNY 31.7B
P/E
12.2x
P/B
1.54x
ROE
15.8%
Dividend yield
3.33%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600079.SHG undervalued?

Graham number
Price19.44
Graham value21.34
Discount8.9%

600079.SHG trades 8.9% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Humanwell Healthcare Group Co Ltd fundamental analysis

No fundamental analysis for Humanwell Healthcare Group Co Ltd yet.

Humanwell Healthcare Group Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Humanwell Healthcare Group Co Ltd

Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for patients who require opioid analgesia; nabuphine hydrochloride injection for use a…

Full company profile